Sangamo Therapeutics H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Brisbane, CA HQ🌐 sangamo.com
Does Sangamo Therapeutics sponsor H-1B visas and green cards?
Yes. Sangamo Therapeutics has filed 55 H-1B LCAs and 2 PERM green-card cases with the U.S. Department of Labor between FY2018 and FY2026. In FY2025 Sangamo Therapeutics filed 2 H-1B LCAs at a median base salary of $144,168, and 1 green-card case was decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2025 | 2 | $144k |
| FY2024 | 3 | $102k |
| FY2023 | 7 | $127k |
| FY2022 | 14 | $144k |
| FY2021 | 14 | $113k |
| FY2020 | 8 | $113k |
| FY2019 | 4 | $69k |
| FY2018 | 3 | $73k |
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
- 1Research Associate II7$75k
- 2Scientist II7$115k
- 3Research Associate III4$98k
- 4Senior Research Associate4$124k
- 5Regulatory Affairs Operations Specialist III3$118k
- 6Associate Director, CMC Regulatory Affairs2$211k
- 7Nonclinical Project Manager2$131k
- 8Process Development Engineer II2$84k
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2025 | 1 | $137k |
| FY2020 | 1 | $91k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 151
- US patents
- Published, not yet granted
- 164
- applications
- Most recent grant
- March 3, 2026
- Top area
- Microorganisms or enzymes; compositions thereof; propagating87
Pay against the local market
Sangamo Therapeutics’s 10 most-filed occupations and metros, FY2018–FY2025. Its median base salary is 90% of the local BLS median for the same work.
| Occupation | Metro | Filings | Sangamo Therapeutics pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Biological Scientists, All Other | San Francisco, CA | 21 | $101,578 | $115,708 | 88% |
| Biochemists and Biophysicists | San Francisco, CA | 13 | $105,482 | $124,915 | 84% |
| Natural Sciences Managers | San Francisco, CA | 4 | $148,146 | $210,085 | 71% |
| Compliance Officers | San Francisco, CA | 3 | $117,000 | $97,120 | 120% |
| Bioengineers and Biomedical Engineers | San Francisco, CA | 3 | $84,781 | $115,567 | 73% |
| Managers, All Other | San Francisco, CA | 3 | $199,899 | $192,670 | 104% |
| Medical Scientists | San Francisco, CA | 3 | $134,772 | $136,057 | 99% |
| Public Relations Specialists | San Francisco, CA | 1 | $73,154 | $72,230 | 101% |
| Computer Occupations, All Other | San Francisco, CA | 1 | $170,000 | $137,210 | 124% |
| Industrial Engineers | San Francisco, CA | 1 | $167,000 | $128,770 | 130% |
About Sangamo Therapeutics
Sangamo Therapeutics is a pharma & biotech company based in Richmond. It was founded in 1995. It is listed on OTC as SGMOQ.
- Name (DOL filings)
- Sangamo Therapeutics
- Listed
- OTC: SGMOQ
- Incorporated in
- Delaware
- Headquarters
- 501 Canal Blvd., Richmond, CA 94084
- Industry
- Pharma & biotech
- Employees (US, est)
- 181 (2024)
- Revenue FY2025
- $40M -32% from $58M
- Net income FY2025
- $-123M -26% from $-98M
- R&D FY2025
- $113M (285% of revenue)
Sangamo Therapeutics pays a median H-1B base of $115,000 across FY2017–2026, about 7% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to Sangamo Therapeutics
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Vir Biotechnology | 77 | 11 | $180k | 2 | — |
| Editas Medicine | 75 | 7 | $102k | 2 | — |
| Revance Therapeutics | 70 | 16 | $143k | 3 | — |
| Sangamo Therapeutics | 55 | 2 | $144k | 0 | — |
| Replimune | 55 | 22 | $158k | 4 | 50% |
| Iovance Biotherapeutics | 54 | 18 | $163k | 1 | — |
| Indivior | 54 | 3 | $120k | 0 | — |
